Ternary nanoparticles of anionic lipid nanoparticles/protamine/DNA for gene delivery

International Journal of Pharmaceutics

Volumn 392, Issue 1-2, 2010, Pages 224-231

  Yuan, Hong ^a   Zhang, Wei ^a   Du, Yong Zhong ^a   Hu, Fu Qiang ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Gene transfection; Lipid nanoparticles; Plasmid DNA; Protamine; Ternary nanoparticles

Indexed keywords

DEOXYRIBONUCLEASE I; GLYCEROL STEARATE; LIPID NANOPARTICLE; NANOPARTICLE; OLEIC ACID; PLASMID DNA; PROTAMINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IC 50; IN VITRO GENE TRANSFER; INTERNALIZATION; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL;

ANIONS; CELL LINE, TUMOR; CELL SURVIVAL; DNA; DRUG CARRIERS; DRUG COMPOUNDING; GENE TRANSFER TECHNIQUES; HUMANS; LIPIDS; LUCIFERASES; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; OLEIC ACID; PARTICLE SIZE; PROTAMINES; SURFACE PROPERTIES; TRANSFECTION;

EID: 77952741502     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.03.025     Document Type: Article

References (34)

1. Anas El-Aneed Current strategies in cancer gene therapy. Eur. J. Pharmacol. 2004, 498:1-8.
2. Balhorn R., Brewer L., Corzett M. DNA condensation by protamine and arginine-rich peptides: analysis of toroid stability using single DNA molecules. Mol. Reprod. Dev. 2000, 56:230-234.
3. Birchall J.C., Kellaway I.W., Cumbleton M. Physical stability and in-vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes. Int. J. Pharmaceut. 2000, 197:221-231.
4. Breunig M., Lungwitx U., Liebl R., Fontanari C., Klar J., Kurtz A., et al. Gene delivery with low molecular weight linear polyethylenimines. J. Gene Med. 2005, 7:1287-1298.
5. Choi Y.R., Chae S.Y., Ahn C.H., Lee M., Oh S., Byun Y., Rhee B.D., Ko K.S. Development of polymeric gene delivery carriers: PEGylated copolymers of L-lysine and L-phenylalanine. J. Drug Target. 2007, 15:391-398.
6. Choi S.H., Jin S.E., Lee M.K., Lim S.J., Park J.S., Kim B.G., Ahn W.S., Kim C.K. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells. Eur. J. Pharm. Biopharm. 2008, 68:545-554.
7. Fischer D., Bieber T., Li Y., Elsasser H.P., Kissel T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm. Res. 1999, 16:1273-1279.
8. Fujita T., Furuhata M., Hattori Y., Kawakami H., Toma K., Maitani Y. High gene delivery in tumor by intratumoral injection of tetraarginine-PEG lipid-coated protamine/DNA. J. Control. Rel. 2008, 129:124-127.
9. Gao X., Huang L. Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry 1996, 35:1027-1036.
10. Gualbert J., Shahgaldian P., Cloleman A.W. Interactions of amphiphilic calix(4)arene-based solid lipid nanoparticles with bovine serum albumin. Adv. Drug Deliv. Tev. 2003, 253:23-38.
11. Hu F.-Q., Jiang S.-P., Du Y.-Z., Yuan H., Ye Y.-Q., Zeng S. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf. B: Biointerf. 2005, 45:167-173.
12. Junghans M., Loitsch S.M., Steiniger S.C., Kreuter J., Zimmer A. Cationic lipid-protamine-DNA (LPD) complexes for delivery of antisense c-myc oligonucleotides. Eur. J. Pharm. Biopharm. 2005, 60:287-294.
13. Junghans M., Loitsch S.M., Steiniger S.C.J., Kreuter J., Zimmer A. Cationic lipid-protamine-DNA (LPD) complexes for delivery of antisense c-myc oligonucleotides. Eur. J. Pharmaceut. Biopharmaceut. 2005, 60:287-294.
14. Kim T.W., Kim Y.J., Chung H., Kwon I.C., Sung H.C., Jeong S.Y. The role of non-ionic surfactants on cationic lipid mediated gene transfer. J. Control. Rel. 2002, 82:455-465.
15. Law S.-L., Chuang T.-C., Kao M.-C., Lin Y.-S., Huang K.-J. Gene transfer mediated by sphingosine/dioleoylphosphatidylethanolamine liposomes in the presence of poloxamer 188. Drug Del. 2006, 13:61-67.
16. Lee R.J., Huang L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem. 1996, 271:8481-8487.
17. Liu F., Yang J., Huang L., Liu D. New cationic lipid formulations for gene transfer. Pharm. Res. 1996, 13:1856-1860.
18. Lonez C., Vandenbranden M., Tuysschaert J.-M. Cationic liposomal lipids: from gene carriers to cell signaling. Progr. Lipid Res. 2008, 47:340-347.
19. Morille M., Passirani C., Vonarbourg A., Clavreul A., Benoit J.-P. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 2008, 29:3477-3496.
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
21. Müller R.H., Mehnert W., Lucks J.S., Schwarz C., zur Mühlen A., Weyhers H., Freitas C., Rühl D. Solid lipid nanoparticles (SLN)-an alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm. 1995, 41:62-69.
22. Olbrich C., Bakowsky U., Lehr C.M., Muller R.H., Kneuer C. Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA. J. Control. Rel. 2001, 77:345-355.
23. Romoren K., Thu B.J., Evensen O. Immersion delivery of plasmid DNA. II. A study of the potentials of a chitosan based delivery system in rainbow trout (Oncorhynchus mykiss) fry. J. Control. Rel. 2002, 85:215-225.
24. Rudolph C., Schillinger U., Ortiz A., Tabatt K., Plank C., Muller R.H., Rosenecker J. Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo. J. Pharm. Res. 2004, 21:1662-1669.
25. Shidhaye S.S., Vaidya R., Sutar S., Patwardhan A., Kadam V.J. Solid lipid nanoparticles and nanostructured lipid carriers--innovative generations of solid lipid carriers. Curr. Drug Deliv. 2008, 5:324-331.
26. Sun X., Hai L., Wu Y., Hu H.Y., Zhang Z.R. Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD). J. Drug Target. 2005, 13:121-128.
27. Tabatt K., Kneuer C., Sameti M., Olbrich C., Muller R.H., Lehr C.M., Bakowsky U. The impact of nanobiotechnology on the development of new drug delivery systems. J. Control. Rel. 2004, 97:321-332.
28. Tranchant T., Besson P., Hoinard C., Delarue J., Antoine J.M., Couet C., Gore J. Mechanisms and kinetics of a-linolenic acid uptake in Caco-2 clone TC7. Biochim. Biophys. Acta 1997, 1345:151-161.
29. Trotta M., Debernardi F., Caputo O. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int. J. Pharm. 2003, 257:153-160.
30. Vaysse L., Gregory L.G., Harbottle R.P., Perouzel E., Tolmachov O., Coutelle C. Nuclear-targeted minicircle to enhance gene transfer with non-viral vectors in vitro and in vivo. J. Gene Med. 2006, 8:754-763.
31. Ward C.M., Read M.L., Seymour L.W. Systemic circulation of poly (L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. Blood 2001, 97:2221-2229.
32. Yuan H., Chen J., Du Y.-Z., Hu F.-Q., Zeng S. Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloids Surf. B: Biointerf. 2007, 58:157-164.
33. Yuan H., Miao J., Du Y.-Z., You J., Hu F.-Q., Zeng S. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int. J. Pharm. 2008, 348:137-145.
34. Ziemienowicz A., Gorlich D., Lanka E., Hohn B., Rossi L. Import of DNA into mammalian nuclei by proteins originating from a plant pathogenic bacterium. Proc. Natl. Acad. Sci. 1999, 96:3729-3733.